These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. Gatchel JR; Donovan NJ; Locascio JJ; Schultz AP; Becker JA; Chhatwal J; Papp KV; Amariglio RE; Rentz DM; Blacker D; Sperling RA; Johnson KA; Marshall GA J Alzheimers Dis; 2017; 59(3):975-985. PubMed ID: 28697559 [TBL] [Abstract][Full Text] [Related]
5. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601 [TBL] [Abstract][Full Text] [Related]
6. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579 [TBL] [Abstract][Full Text] [Related]
7. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly. Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040 [TBL] [Abstract][Full Text] [Related]
8. Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels. Babulal GM; Ghoshal N; Head D; Vernon EK; Holtzman DM; Benzinger TLS; Fagan AM; Morris JC; Roe CM Am J Geriatr Psychiatry; 2016 Nov; 24(11):1095-1104. PubMed ID: 27426238 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals. Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070 [TBL] [Abstract][Full Text] [Related]
10. Amyloid Burden and Depressive Symptom Trajectories in Older Adults at Risk of Developing Cognitive Decline. Conejero I; Dubois J; Gutierrez LA; Delrieu J; Arbus C; Garcia M; Lopez-Castroman J; Courtet P; Gabelle A J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34352166 [No Abstract] [Full Text] [Related]
11. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Oh H; Madison C; Baker S; Rabinovici G; Jagust W Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008 [TBL] [Abstract][Full Text] [Related]
12. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]
13. Associations of the Rate of Change in Geriatric Depression Scale with Amyloid and Cerebral Glucose Metabolism in Cognitively Normal Older Adults: A Longitudinal Study. Wang ZT; Shen XN; Ma YH; Ou YN; Dong PQ; Tan PL; Yu PJ; J Affect Disord; 2021 Feb; 280(Pt A):77-84. PubMed ID: 33202341 [TBL] [Abstract][Full Text] [Related]